FIGURE

Fig. 2

ID

ZDB-FIG-171011-8

Publication

Fang et al., 2014 - A novel model of demyelination and remyelination in a GFP-transgenic zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

Mtz treatment specifically depletes oligodendrocytes of Tg(mbp:nfsB-egfp).

Panels A,B demonstrate that EGFP is expressed in larvae from the 5 dpf control group and Mtz treatment group before Mtz treatment (white arrowheads), respectively. In control larva, EGFP was strongly expressed (C, white arrowhead) at 10 dpf. Panel D shows the EGFP expression in larva from the Mtz treatment group at 10 dpf after an exposure to 5 mM Mtz for 5 days. Note that the fluorescence signals were significantly reduced along the spinal cord (white arrowhead). Panel E is the result of a western blot with the MBP antibody at 5 dpf and 10 dpf. Note that the MBP protein expression was significantly suppressed in the Mtz treatment larvae at 10 dpf (F). Dorsal is up and rostral is left in Panels A–D. Scale bar: 100 µm.

Expression Data

Gene:	EGFP
Antibody:	Ab2-mbp
Fish:	nku1Tg (AB)
Condition:	chemical treatment by environment: metronidazole
Anatomical Terms:	spinal cord whole organism
Stage:	Days 7-13

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	nku1Tg (AB)
Condition:	chemical treatment by environment: metronidazole
Observed In:	spinal cord spinal cord myelination spinal cord oligodendrocyte whole organism
Stage:	Days 7-13

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biol. Open